DEADLINE FOR CONCEPT PROPOSALS; January 12th, 2024, 2-4 pilot grants will be funded, Up to $40,000 total costs per grant. The purpose of this program is to promote multidisciplinary research in Georscience and HIV by bridging research excellence between CFAR, OAIC, NSC, and MBI and developing the next generation of HIV Geroscience Researchers. Proposals with…Continue Reading 2024 HIV and Aging Pilot Funding: Request for Applications
Notice of Special Interest (NOSI): Ending the HIV Epidemic (EHE)
Notice of Special Interest (NOSI): Ending the HIV Epidemic (EHE) Notice Number: NOT-AI-23-070 Key Dates: PURPOSE: The objective of this Notice of Special Interest (NOSI) is to solicit applications proposing research that is grounded in implementation science and can address the goals of the Ending the HIV Epidemic in the U.S. (EHE) initiative. The overall…Continue Reading Notice of Special Interest (NOSI): Ending the HIV Epidemic (EHE)
CFAR AFRICURE Developmental Award: Concept Proposal due November 7, 2023
This AFRICURE program program is funded by the US National Institutes of Health & National Institute on Minority Health and Health Disparities, and administered through the Johns Hopkins University Center for AIDS Research (CFAR) & Inter-CFAR Sub-Saharan Africa Working Group. Important Dates: The AFRICURE program will award five grants of $150,000 for one year, plus…Continue Reading CFAR AFRICURE Developmental Award: Concept Proposal due November 7, 2023
October 15 is National Latinx AIDS Awareness 2023: Spark Conversations Around You
October 15 is the 20th anniversary of National Latinx AIDS Awareness Day (NLAAD) and a recognition of the unique HIV-related challenges faced by the Hispanic/Latinx community. NLAAD is an opportunity to help address the disproportionate impact of HIV on Hispanic/Latinx communities, promote HIV testing, and stop HIV stigma….Continue Reading October 15 is National Latinx AIDS Awareness 2023: Spark Conversations Around You
Interested in joining: Inter-CFAR Transgender Health Working Group
The goal of the Inter-CFAR Transgender Health Working Group is to bring together researchers and communities across the CFARs working to promote the health and well-being of transgender communities. The pooled knowledge and resources of the group support the following working group pillars: Membership is available to all investigators at CFAR institutions. Anyone interested in…Continue Reading Interested in joining: Inter-CFAR Transgender Health Working Group
Job Posting: The San Diego CFAR Administrative Core is currently hiring a Program Manager for its Developmental and International Core
The job can be found here: https://employment.ucsd.edu/program-manager-124858/job/26090874 Download the job description posted below:…Continue Reading Job Posting: The San Diego CFAR Administrative Core is currently hiring a Program Manager for its Developmental and International Core
Medscape InDiscussion Podcast with Rajesh Gandhi: “What’s New in the Field of Antiretroviral Therapy Guidelines for HIV?”
The episode discusses antiretroviral therapy (ART) guidelines and what’s new in the field? To listen to the podcast click here (https://www.medscape.com/viewarticle/986509?src=&form=fpf)….Continue Reading Medscape InDiscussion Podcast with Rajesh Gandhi: “What’s New in the Field of Antiretroviral Therapy Guidelines for HIV?”
Career Catalyst Opportunity
DATES: Apply by June 30, 2023 | September 2023 – June 2024 THE PROGRAM: One-year strategic mentoring program for early-career researchers. Learn how to create a successful mentee-mentor relationship, build a mentoring network, and grow your career. PARTICAPATE IN THE FOLLOWING EVENTS THROUGHOUT THE YEAR: APPLY HERE: Career Catalyst mentoring program (https://hms.az1.qualtrics.com/jfe/form/SV_6gSBVdudxa1z1MG)…Continue Reading Career Catalyst Opportunity
Progress towards a safe and effective vaccine for HIV (first-in-human trial)
To read more about the this see the HIV.gov blog (https://www.hiv.gov/blog/encouraging-first-in-human-results-for-a-promising-hiv-vaccine/?utm_source=email&utm_medium=email&utm_campaign=Weekly20230609)…Continue Reading Progress towards a safe and effective vaccine for HIV (first-in-human trial)